Wuhan Healthgen Biotechnology Corp Class ASSE: 688765

"WUHAN HEALTHGEN BIOTECHNOLOGY CORP."Semi-annual Report for 2026

Aug 27, 2026 · Issued by Wuhan Healthgen Biotechnology Corp Class A via Shanghai Stock Exchange

Semi-annual Report for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Wuhan Healthgen Biotechnology Corp Class A

"WUHAN HEALTHGEN BIOTECHNOLOGY CORP."Announcement on Listing and Trading of Certain Restricted Shares from Offline Placement in the Initial Public OfferingJul 21
"WUHAN HEALTHGEN BIOTECHNOLOGY CORP."Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction and 2025 Annual Performance BriefingJul 2
Announcement on Wholly-owned Subsidiary Opening Special Account for Raised Funds and Signing Supervision AgreementJun 25
Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business LicenseJun 2

All Wuhan Healthgen Biotechnology Corp Class A news releases